[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., Obarzanek E., Conlin P.R., Miller E.R., Simons-Morton D.G., et al
References 1 AbouelkheirM.El-MetwallyT
Retatrutide has not yet been approved by any regulatory agency, including the FDA in the United States and the MHRA in the UK, and its safety is still being evaluated
No commitment beyond each month, but the per-month cost is significantly higher than the quarterly option
The use of this medication class for weight loss indeed has skyrocketed
As previously mentioned, how your digestive system responds to your diet and to semaglutide can be highly individualized